A study by Magi-Galluzzi et al. about prostate cancer (Pca) revealed that TMPRSS2-ERG fusion was significantly correlated with ethnicity and geography (50% of Caucasians, 31.3% African-Americans, and 15.9% of Japanese patients) [5]. This evidence concerns the gene TMPRSS2 and prostate cancer.